www.fdanews.com/articles/203203-teleglobals-chest-abnormality-detection-software-awarded-ce-mark
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
Teleglobal’s Chest Abnormality Detection Software Awarded CE Mark
June 17, 2021
Teleglobal Consulting UK’s artificial intelligence software for detecting chest abnormalities has received a CE mark.
The software, sold under the brand name iDoc.ai, can detect 13 types of chest conditions, including those caused by COVID-19.
The software also has certification under ISO 13485, and is now available in Europe and other markets that accept the CE mark.